Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results
Guillaume Schurtz,1,2 Cédric Delhaye,1 Christopher Hurt,1,2 Henri Thieuleux,1,2 Gilles Lemesle1–3 1Centre Hémodynamique et Unité des Soins Intensifs de Cardiologie, Hôpital Cardiologique, Centre Hospitalier Régional et Universitaire de...
Guardado en:
Autores principales: | Schurtz G, Delhaye C, Hurt C, Thieuleux H, Lemesle G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1de71d35015a4d89a590d1e8e14e5519 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
por: Jonathan Bridges, et al.
Publicado: (2008) -
Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas VF, et al.
Publicado: (2015) -
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients
por: Wiemer M, et al.
Publicado: (2015) -
Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
por: Brendan Doyle, et al.
Publicado: (2009)